Evidence map›Paper›PMID 34825039›Full record

ArticleJAAD case reports2021

A novel

Qisi Sun, Jeff R Gehlhausen, Marianna Freudzon, Nour Kibbi, Allen Bale, Keith Choate, Mary Tomayko, Ian Odell, Sarika Ramachandran

Abstract readCase Reports
In one paragraph

Article in JAAD case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. DetrimentalFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qisi SunDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Jeff R GehlhausenDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Marianna FreudzonDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Nour KibbiDepartment of Dermatology, Stanford University School of Medicine, Stanford, California.
Allen BaleDepartment of Genetics, Yale University School of Medicine, New Haven, Connecticut.
Keith ChoateDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Mary TomaykoDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Ian OdellDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Sarika RamachandranDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CVID, common variable immunodeficiencydermatosesgeneticsimmunodeficiencyinflammatoryneutrophilicNF-κB, Nuclear-factor kappa BPG, pyoderma gangrenosumpyoderma gangrenosumulcers

Identifiers

PMID34825039
PMCPMC8605275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.